about
Follow-up Creatinine Level Is an Important Predictive Factor of In-hospital Mortality in Cirrhotic Patients with Spontaneous Bacterial Peritonitis.Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control StudyCombined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for ≤5cm hepatocellular carcinoma: Propensity score matching analysisReal-Life Effectiveness and Safety of Sofosbuvir-Based Therapy in Genotype 2 Chronic Hepatitis C Patients in South Korea, with Emphasis on the Ribavirin DoseChange in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous ObliterationAppraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage BPrevalence, incidence and risk factors of tamoxifen-related non-alcoholic fatty liver disease: A systematic review and meta-analysisDiscontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre studyEpidemiological and Clinical Characteristics of Hepatitis C Virus Infection in South Korea from 2007 to 2017: A Prospective Multicenter Cohort StudyRelation of fibroblast growth factor receptor 2 expression to hepatocellular carcinoma recurrence after liver resectionReal-life effectiveness and safety of the daclatasvir/asunaprevir combination therapy for genotype 1b chronic hepatitis C patients: An emphasis on the pretreatment NS5A resistance-associated substitution test
P50
Q54977328-70DF053E-3EF8-4202-BE25-76054524D0C5Q57469986-4A17D5D6-9E60-4E13-88B8-AC6744365D5EQ58091177-7A9A608E-4D4A-4604-94BB-82D989EAC187Q89448325-A301F5BA-CE54-4186-ABB4-6619EC6FBD17Q89683447-28B81BE8-6516-4963-84FB-DB2C07BE874BQ90164593-5832D352-C4EB-4568-A94C-50A80BB0726AQ90322370-FBB011FF-0A2B-4DF8-BDAC-1B634525921EQ90629255-E15B3FA1-8E93-4E01-9DF4-956A8941F77FQ92492102-7B925F93-D02F-4658-96F8-B01573D0CD99Q92659275-9F9B592F-F0E0-4046-BA9C-386475FB859BQ92886337-F2B587E9-0769-47DC-A0B8-0C3503A889E5
P50
description
researcher (ORCID 0000-0002-7113-3623)
@en
name
Young Seok Kim
@en
type
label
Young Seok Kim
@en
prefLabel
Young Seok Kim
@en
P31
P496
0000-0002-7113-3623